The Effect of Fiber-Reinforced Composites on Quality of Life and Bone Height in Maxillary Implant Arches

Launched by CAIRO UNIVERSITY · Aug 27, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how a special type of dental framework, made from a glass fiber composite, can impact the quality of life and bone height in patients who have lost all their upper teeth (a condition called edentulous). Specifically, the study will follow patients over a year to see how this temporary framework affects them before they receive a more permanent dental prosthesis. The goal is to understand if this approach can help improve the overall experience of patients receiving dental implants.

To be eligible for this study, participants need to be between 40 and 65 years old and must have a healthy amount of gum tissue and bone to support dental implants. They should also have good oral hygiene and no serious medical conditions that could complicate the dental work. Participants will not be allowed if they have had recent tooth extractions, certain infections, or if they smoke heavily. Those who join can expect to be part of a process that assesses their comfort and dental health over the course of a year, contributing to important research in dental care.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • • Completely edentulous patients with Angle's Class I maxillomandibular relationship
• • Age ranges from 40 to 65 years old.
• • Adequate zone of keratinized attached mucosa (≥ 8mm) over the maxillary crest.
• • Absence of any medical disorder that could complicate the surgical phase or affect osseointegration.
• • The patient must have enough bone height for implants, a minimum length of bone
• • 12 mm, and a minimum diameter of bone 6 mm.
• • Patients with good oral hygiene.
• • Adequate inter arch space for screw-retained prosthesis.
• • Absence of any intra-oral pathological condition.
• Exclusion Criteria:
• • • Patients with recent extraction (less than three months).
• • Patients with an inflamed ridge or candida infection
• • Patients with the flabby ridge.
• • Para functional habits.
• • Cancer patients receiving chemotherapy and/or radiotherapy.
• • Patients with uncontrolled diabetes, assessed by measuring glycosylated hemoglobin (HbA1c ≥ 7)
• • Potentially uncooperative patients who are not willing to go through the proposed interventions.
• • Moderate-to-heavy daily smokers (more than ten per day)